Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Drug Manufacturers - Major Cannabis Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp > Anyone else notice this?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(30)
•••
Comment by Rune505on Mar 26, 2021 6:45pm
213 Views
Post# 32891434

RE:Anyone else notice this?

RE:Anyone else notice this?

Interesting.  According to Barrons and Forbes, the SAFE Act would only allow for banking/loan privileges excluding uplisting.

Page 5 of the SAFE Act talks about protections for ancillary business's.  This could imply protections for major trade exchanges but a lawyer would be better suited for interpretation.  There is nothing in act that explicitly makes allowances for uplisting so most of what's in the news is probably conjecture and we likely won't know for sure until the act passes.

The act is included at the bottom of this article:
https://www.marijuanamoment.net/marijuana-banking-bill-reintroduced-in-senate-with-nearly-a-third-of-the-chamber-signed-on/


 


WestCoast78 wrote: This is from last Friday.  Im not sure how accurate he is, but David George Cosh mentions the word uplist, referencing the safe banking act.

1:18 mark

https://www.bnnbloomberg.ca/marijuana

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities